ArticleAbdominal radiology (New York)2026
Analysis of deep learning-based segmentation of lymph nodes on full-dose and reduced-dose body CT.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe performance of fully automated deep learning-based models for the detection and segmentation of lymph nodes (LNs) on full- and simulated reduced-dose CT was validated.
methodsA total of 15,341 LNs were annotated in 151 patient CTs (age 52 ± 14 years, 87 males) from the public TCIA NIH CT Lymph Nodes dataset. Two 3D nnU-Net models were trained on 90 CT scans: (1) only full dose CTs (NoAugmentation), and (2) both full- and reduced-dose CTs (Augmentation). Dose reduction from 75% to 5% of the full-dose was simulated using a noise-addition tool. Performance was validated on the remaining 61 CTs and an external TCIA Mediastinal LNQ dataset (120 CTs, 64 females).
resultsOn 61 full-dose CTs, the Augmentation model detected all LNs with 67.3% precision and 84.6% sensitivity. For all LNs and large nodes (short axis diameter ≥ 8 mm), Dice Similarity Coefficient (DSC) was 0.83 ± 0.07 and 0.80 ± 0.14, while Hausdorff Distance (HD) error was 1.47 ± 0.91 mm and 3.2 ± 2.28 mm, respectively. Performance decreased with dose reduction (p < 0.01), reaching 73.8% detection sensitivity and 0.75 DSC at 5% dose. Statistically significant differences between Augmentation vs. NoAugmentation models were seen for all nodes (p < 0.001) and small nodes (p < 0.05) at 10% and 5% doses. On the external LNQ dataset, the Augmentation model attained a DSC of 0.76 ± 0.12 and HD of 4.7 ± 3.23 (p < 0.01) for all LNs.
conclusionDegraded image quality impacted nodal delineation on reduced-dose CT. Performance improved when a model trained on both full- and reduced-dose CTs was used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.